Batavia to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines...
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and...
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel...
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet...
Oxford researchers launch HIV vaccine trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine...
Roche & Mimetas collaborate to develop human disease models for drug development
Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human...
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research...
Recipharm signs Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics...
Global contract development and manufacturing organisation (CDMO), Recipharm, has signed an MOU, along with His...
GSK and Alector to develop antibodies for neurodegenerative diseases
GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of...
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, and Torrent...
Sanofi launches dedicated vaccines mRNA Center of Excellence
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of...
